Development of a shared decision-making tool in vitiligo: an international study

J Shourick1, M Ahmed2, J Seneschal3

  • 1Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE), EA7379, Paris-Est University, UPEC, DHU VIC, Créteil, France.

Summary

A new shared decision-making tool (SDMT) was developed for vitiligo patients. This validated tool aids joint medical decisions between physicians and patients, addressing treatment goals and disease management.